174 related articles for article (PubMed ID: 34302367)
21. Survival after transcoronary ablation of septal hypertrophy in hypertrophic obstructive cardiomyopathy (TASH): a 10 year experience.
Kuhn H; Lawrenz T; Lieder F; Leuner C; Strunk-Mueller C; Obergassel L; Bartelsmeier M; Stellbrink C
Clin Res Cardiol; 2008 Apr; 97(4):234-43. PubMed ID: 18071624
[TBL] [Abstract][Full Text] [Related]
22. Surgical septal myectomy or alcohol septal ablation: which approach offers better outcomes for patients with hypertrophic obstructive cardiomyopathy?
Poon SS; Field M; Gupta D; Cameron D
Interact Cardiovasc Thorac Surg; 2017 Jun; 24(6):951-961. PubMed ID: 28329292
[TBL] [Abstract][Full Text] [Related]
23. [Long-term outcome and related predictors of alcohol septal ablation for patients with hypertrophic obstructive cardiomyopathy].
Liu R; Qiao SB; Hu FH; Yang WX; Yuan JS; Cui JG
Zhonghua Xin Xue Guan Bing Za Zhi; 2016 Sep; 44(9):771-776. PubMed ID: 27667275
[No Abstract] [Full Text] [Related]
24. Short- and long-term outcome after alcohol septal ablation in obstructive hypertrophic cardiomyopathy: Experience of a reference center.
Aguiar Rosa S; Fiarresga A; Galrinho A; Cacela D; Ramos R; de Sousa L; Gonçalves A; Bernardes L; Patrício L; Branco LM; Ferreira RC
Rev Port Cardiol (Engl Ed); 2019 Jul; 38(7):473-480. PubMed ID: 31495717
[TBL] [Abstract][Full Text] [Related]
25. Long-term survival after alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a comparison with general population.
Veselka J; Krejčí J; Tomašov P; Zemánek D
Eur Heart J; 2014 Aug; 35(30):2040-5. PubMed ID: 24464834
[TBL] [Abstract][Full Text] [Related]
26. [Long-term outcome of patients with hypertrophic obstructive cardiomyopathy post percutaneous transluminal septal ablation].
Zheng SW; Shi HY; Dai JJ; Chen H; Wu WH; Qiu XB
Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Apr; 48(4):294-301. PubMed ID: 32370480
[No Abstract] [Full Text] [Related]
27. Continuous rhythm monitoring for ventricular arrhythmias after alcohol septal ablation for hypertrophic cardiomyopathy.
Balt JC; Wijffels MC; Boersma LV; Wever EF; ten Berg JM
Heart; 2014 Dec; 100(23):1865-70. PubMed ID: 25073885
[TBL] [Abstract][Full Text] [Related]
28. Safety and efficacy of coil embolization of the septal perforator for septal ablation in patients with hypertrophic obstructive cardiomyopathy.
Guerrero I; Dhoble A; Fasulo M; Denktas AE; Sami S; Choi S; Balan P; Arain SA; Smalling RW
Catheter Cardiovasc Interv; 2016 Nov; 88(6):971-977. PubMed ID: 27511120
[TBL] [Abstract][Full Text] [Related]
29. Predictors of long-term outcome after septal myectomy in symptomatic hypertrophic obstructive cardiomyopathy patients with previous alcohol septal ablation and residual obstruction.
Zhu C; Tang B; Cui H; Wang S; Xiao M; Chen Z; Meng Y; Zhao S; Song Y; Yu Q; Wang S
J Card Surg; 2019 Jul; 34(7):533-540. PubMed ID: 31111576
[TBL] [Abstract][Full Text] [Related]
30. Guideline-Based Referral for Septal Reduction Therapy in Obstructive Hypertrophic Cardiomyopathy Is Associated With Excellent Clinical Outcomes.
Kimmelstiel C; Zisa DC; Kuttab JS; Wells S; Udelson JE; Wessler BS; Rastegar H; Kapur NK; Weintraub AR; Maron BJ; Maron MS; Rowin EJ
Circ Cardiovasc Interv; 2019 Jul; 12(7):e007673. PubMed ID: 31296080
[TBL] [Abstract][Full Text] [Related]
31. Effects of surgical septal myectomy on survival in patients with hypertrophic obstructive cardiomyopathy.
Meng X; Liang M; Shi Y; Zhang W; Zhou S; Gao C
Anatol J Cardiol; 2020 Jun; 23(6):342-348. PubMed ID: 32478684
[TBL] [Abstract][Full Text] [Related]
32. Incidence of Atrial Fibrillation following Alcohol Septal Ablation for Hypertrophic Cardiomyopathy.
Moss TJ; Zipse MM; Krantz MJ; Sauer WH; Salcedo EE; Schuller JL
Ann Noninvasive Electrocardiol; 2016 Sep; 21(5):443-9. PubMed ID: 26970562
[TBL] [Abstract][Full Text] [Related]
33. Effectiveness of Alcohol Septal Ablation in Obstructive Hypertrophic Cardiomyopathy With Versus Without Extreme Septal Hypertrophy.
Yang YJ; Fan CM; Yuan JQ; Wang ZM; Duan FJ; Qiao SB; You SJ; Yuan JS; Hu FH; Yang WX; Guo XY; Li YS
J Invasive Cardiol; 2016 Mar; 28(3):99-103. PubMed ID: 26945252
[TBL] [Abstract][Full Text] [Related]
34. Long-term clinical and echocardiographic outcomes of extensive septal myectomy for hypertrophic obstructive cardiomyopathy in Chinese patients.
Yao L; Li L; Lu XJ; Miao YL; Kang XN; Duan FJ
Cardiovasc Ultrasound; 2016 May; 14(1):18. PubMed ID: 27189485
[TBL] [Abstract][Full Text] [Related]
35. Alcohol dose in septal ablation for hypertrophic obstructive cardiomyopathy.
Veselka J; Faber L; Liebregts M; Cooper R; Januska J; Kashtanov M; Dabrowski M; Hansen PR; Seggewiss H; Bonaventura J; Polakova E; Hansvenclova E; Bundgaard H; Ten Berg J; Stables RH; Jarkovsky J; Jensen MK
Int J Cardiol; 2021 Jun; 333():127-132. PubMed ID: 33647367
[TBL] [Abstract][Full Text] [Related]
36. Alcohol septal ablation in hypertrophic cardiomyopathy utilizing a longitudinal 17-year study (mean 10.8). Observation follow-ups taken at a single medical centre.
Wojtarowicz A; Kornacewicz-Jach Z
Cardiol J; 2017; 24(2):125-130. PubMed ID: 27734458
[TBL] [Abstract][Full Text] [Related]
37. Looking back on 15 years of ultrasound-guided alcohol septal ablation for hypertrophic obstructive cardiomyopathy.
Vermaete I; Dujardin K; Stammen F
Acta Cardiol; 2020 Oct; 75(6):483-491. PubMed ID: 31204591
[No Abstract] [Full Text] [Related]
38. Effect of Institutional Experience on Outcomes of Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy.
Veselka J; Faber L; Jensen MK; Cooper R; Januska J; Krejci J; Bartel T; Dabrowski M; Hansen PR; Almaas VM; Seggewiss H; Horstkotte D; Adlova R; Bundgaard H; Ten Berg J; Liebregts M
Can J Cardiol; 2018 Jan; 34(1):16-22. PubMed ID: 29275877
[TBL] [Abstract][Full Text] [Related]
39. Risk marker profiles in patients treated with percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy.
Burghardt A; van Buuren F; Dimitriadis Z; Grübbel T; Seggewiss H; Scholtz S; Horstkotte D; Faber L
Clin Res Cardiol; 2018 Jun; 107(6):479-486. PubMed ID: 29453593
[TBL] [Abstract][Full Text] [Related]
40. Incidence and predictors of late complete heart block after alcohol septal ablation treatment of hypertrophic obstructive cardiomyopathy.
Schuller JL; Zipse MM; Krantz MJ; Blaker B; Salcedo E; Groves BM; Messenger JC; Beaty B; Sauer WH
J Interv Cardiol; 2015 Feb; 28(1):90-7. PubMed ID: 25689552
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
